北美发作性睡病市场至 2027 年 - 按类型划分的区域分析和预测（伴有猝倒的发作性睡病、不伴有猝倒的发作性睡病和继发性发作性睡病）；产品（中枢神经系统（CNS）兴奋剂、羟丁酸钠和抗抑郁药）；分销渠道（医院药房和零售药房）和国家
No. of Pages: 118 | Report Code: TIPRE00008100 | Category: Life Sciences
No. of Pages: 118 | Report Code: TIPRE00008100 | Category: Life Sciences
北美嗜睡症市场预计将从 2018 年的 9.196 亿美元增至 2027 年的 20.248 亿美元。从 2019 年起，嗜睡症市场预计将以 9.3% 的复合年增长率增长 - 2027 年。
由于主要驱动力，嗜睡症市场预计将增长睡眠障碍的增加和制药业的发展等因素。然而，市场预计将面临发作性睡病无法治愈等制约因素
发作性睡病是一种慢性神经系统疾病；这种疾病会影响大脑控制睡眠和觉醒周期的能力。一个人可能在儿童期、青年期或成年期（17 岁至 25 岁）受到该疾病的影响。最常见的症状是白天过度嗜睡、猝倒、睡眠麻痹和幻觉。这种疾病是北美地区人们常见的疾病，也是导致白天过度嗜睡的第二大原因。根据国家罕见疾病组织的数据，发作性睡病的发病率为两千分之一。同样，根据美国国家神经疾病和中风研究所的数据，估计全美有近 135,000 至 200,000 人患有发作性睡病。
睡眠障碍的增加正在影响人们的工作效率，也影响着表现参与研究的儿童。同样，它也影响着老年人。随着年龄的增长，这种疾病的风险会增加，并且可能会在睡眠期间停止呼吸活动。牛津学术界 2018 年 4 月发表的研究表明，这种情况在女性中普遍存在。研究还指出，21-30岁年龄段人群的发病率较高。人们还预计，对于有遗传倾向的个体来说，发作性睡病是由在开始年龄之前的环境暴露引起的。
预计未来几年睡眠障碍的发病率可能会增加。睡眠障碍已成为北美地区人民的一大担忧。该地区有超过 5000 万人患有 80 多种不同的睡眠障碍，每年有近 20 至 3000 万人患有周期性睡眠障碍。因此，日益严重的睡眠障碍可能需要治疗发作性睡病，这最终将导致未来市场的增长。
p>
北美发作性睡病 -市场细分
北美嗜睡症市场–按类型
北美市场 -副产品
北美市场 -按分销渠道
按地理位置
< span>
Strategic insights for North America Narcolepsy involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2018 | US$ 919.6 Million |
| Market Size by 2027 | US$ 2,024.8 Million |
| Global CAGR (2019 - 2027) | 9.3% |
| Historical Data | 2016-2017 |
| Forecast period | 2019-2027 |
| Segments Covered |
By 类型
|
| Regions and Countries Covered | 北美
|
| Market leaders and key company profiles |
The regional scope of North America Narcolepsy refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The List of Companies - North America Narcolepsy Market
The North America Narcolepsy Market is valued at US$ 919.6 Million in 2018, it is projected to reach US$ 2,024.8 Million by 2027.
As per our report North America Narcolepsy Market, the market size is valued at US$ 919.6 Million in 2018, projecting it to reach US$ 2,024.8 Million by 2027. This translates to a CAGR of approximately 9.3% during the forecast period.
The North America Narcolepsy Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Narcolepsy Market report:
The North America Narcolepsy Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Narcolepsy Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Narcolepsy Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
UK+442030260021, US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For North America Narcolepsy Market
